PACS Group (NYSE:PACS) Given New $52.00 Price Target at Royal Bank Of Canada

PACS Group (NYSE:PACS) had its price objective hoisted by equities research analysts at Royal Bank Of Canada from $47.00 to $52.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada’s target price indicates a potential upside of 40.74% from the stock’s previous close.

Several other equities analysts have also commented on PACS. Truist Financial set a $40.00 target price on shares of PACS Group in a report on Friday, December 12th. UBS Group restated a “buy” rating and set a $42.00 price target (down from $50.00) on shares of PACS Group in a research report on Thursday, December 18th. Wall Street Zen upgraded PACS Group from a “hold” rating to a “buy” rating in a report on Sunday, February 15th. Zacks Research raised PACS Group from a “strong sell” rating to a “hold” rating in a research note on Friday, January 30th. Finally, JPMorgan Chase & Co. started coverage on PACS Group in a research report on Wednesday, December 17th. They set an “overweight” rating and a $44.00 price target on the stock. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, PACS Group currently has an average rating of “Moderate Buy” and an average price target of $44.50.

PACS Group Price Performance

NYSE PACS traded down $4.72 on Friday, reaching $36.95. 1,769,123 shares of the company’s stock traded hands, compared to its average volume of 1,086,174. PACS Group has a 12 month low of $7.50 and a 12 month high of $43.08. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.94 and a quick ratio of 0.94. The stock has a 50-day simple moving average of $38.15 and a 200 day simple moving average of $24.08. The stock has a market cap of $5.79 billion, a PE ratio of 35.20, a P/E/G ratio of 1.31 and a beta of -0.65.

Hedge Funds Weigh In On PACS Group

Several hedge funds have recently made changes to their positions in PACS. Alyeska Investment Group L.P. lifted its stake in PACS Group by 159.5% in the fourth quarter. Alyeska Investment Group L.P. now owns 2,250,007 shares of the company’s stock worth $86,378,000 after acquiring an additional 1,382,984 shares during the period. Crewe Advisors LLC boosted its stake in shares of PACS Group by 93.1% during the 4th quarter. Crewe Advisors LLC now owns 2,147,815 shares of the company’s stock valued at $82,455,000 after purchasing an additional 1,035,747 shares in the last quarter. Royce & Associates LP increased its position in shares of PACS Group by 76.6% during the third quarter. Royce & Associates LP now owns 1,859,070 shares of the company’s stock valued at $25,525,000 after buying an additional 806,446 shares during the period. Marshall Wace LLP raised its stake in PACS Group by 348.6% in the third quarter. Marshall Wace LLP now owns 1,010,906 shares of the company’s stock worth $13,880,000 after buying an additional 785,537 shares in the last quarter. Finally, Ameriprise Financial Inc. lifted its holdings in PACS Group by 120.4% in the second quarter. Ameriprise Financial Inc. now owns 1,129,612 shares of the company’s stock worth $14,595,000 after buying an additional 617,124 shares during the period.

PACS Group Company Profile

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.